Ocal Serpil, Ortac Ersoy Ebru, Ozturk Ozge, Hayran Mutlu, Topeli Arzu, Coplu Lutfi
Hacettepe University, Faculty of Medicine, Medical Intensive Care Unit, Ankara, Turkey.
Hacettepe University, Faculty of Medicine, Department of Chest Diseases, Ankara, Turkey.
Clin Respir J. 2017 Nov;11(6):975-982. doi: 10.1111/crj.12450. Epub 2016 Feb 15.
Chronic obstructive pulmonary disease (COPD) remains a globally significant cause of mortality, although COPD mortality varies from country to country, and across different regions within each country. The primary objective of this study was to determine the mortality rates of COPD patients who present with acute respiratory failure (ARF) to a tertiary care referral center in different stages of their follow-up (ICU, in-hospital and after discharge). The secondary objective was to determine factors associated with mortality in this group of patients.
Medical records of consecutive COPD patients over a 10-year period were reviewed.The study included 147 patients. Of these, 72 were treated initially with noninvasive positive pressure ventilation (NIPPV), and 12 of these required intubation after NIPPV failed. Therefore, 86 patients were intubated for invasive mechanical ventilation (IMV), while NIPPV was succesful in 60 patients. Survival time was independently associated with advanced age, high APACHE II score, co-morbidity and the need for IMV. The cumulative mortality was 27% in the medical ICU and 31% in hospital following ICU discharge. The mortality rate at 1, 2 and 5 years was 54%, 66% and 84%, respectively.
COPD patients admitted to the ICU for ARF have an approximately 70% chance of leaving hospital alive, but half of these may die in the first 6 months after discharge. The risk factors related to mortality were advanced age, high APACHE II score, co-morbidity and IMV requirement.
慢性阻塞性肺疾病(COPD)仍是全球范围内一个重要的死亡原因,尽管COPD死亡率在不同国家以及每个国家的不同地区存在差异。本研究的主要目的是确定在三级医疗转诊中心就诊的急性呼吸衰竭(ARF)COPD患者在不同随访阶段(重症监护病房、住院期间及出院后)的死亡率。次要目的是确定该组患者中与死亡率相关的因素。
回顾了连续10年COPD患者的病历。该研究纳入了147例患者。其中,72例最初接受无创正压通气(NIPPV)治疗,其中12例在NIPPV失败后需要插管。因此,86例患者接受有创机械通气(IMV)插管,而60例患者NIPPV治疗成功。生存时间与高龄、高APACHE II评分、合并症以及IMV需求独立相关。在医疗重症监护病房累积死亡率为27%,重症监护病房出院后住院期间为31%。1年、2年和5年的死亡率分别为54%、66%和84%。
因ARF入住重症监护病房的COPD患者有大约70%的机会存活出院,但其中一半可能在出院后的前6个月内死亡。与死亡率相关的危险因素为高龄、高APACHE II评分、合并症以及IMV需求。